10/31/2013 - 2:38pm

Earlier this year, the Food and Drug Administration approved a new drug for treating cystic fibrosis for patients who have a specific genetic mutation, but that also treats the underlying cause of the disease rather than the disease itself.

10/31/2013 - 2:23pm

A personalized medicine company said a new study justifies clinical use of pharmacogenomic testing to help predict patients' response to psychiatric medications and improve treatment outcomes.

10/30/2013 - 2:58pm

A trade group for supplement makers is suggesting that people with diabetes talk to their physicians about chromium picolinate supplementation, based on a recent study.

10/30/2013 - 1:29pm

Vaccination of adolescents against whooping cough appears to result in fewer hospitalizations, according to a new study.

10/28/2013 - 2:01pm

A growing number of consumers are concerned about their privacy when they sign up for loyalty card programs, according to a new survey.

10/25/2013 - 2:59pm

The Food and Drug Administration plans to officially recommend that products containing 15 mg or less of the opioid painkiller hydrocodone be rescheduled as Schedule II controlled substances, from the current Schedule III classification. While the idea is to combat abuse and misuse of the drugs, pharmacy groups say the rescheduling would make them harder to obtain for patients who legitimately need them.

The desire to combat abuse and misuse of prescription drugs — now a worse problem in the United States than cocaine or heroin — is laudable, but unlike those two drugs, hydrocodone has a legitimate use as a painkiller, and it's the people who are using it properly and legally who will end up losing.

10/25/2013 - 2:51pm

With is proposed acquisition of German wholesaler Celesio, McKesson creates a global distribution enterprise on the scale of Walgreens, Alliance Boots and AmerisourceBergen before them. In addition to wholesaling, Celesio operates about 2,200 pharmacies across six countries and is the No. 2 operator in the United Kingdom.

Retail pharmacy and drug sourcing both are more and more becoming a global business. Just last week, the head of the second-biggest drug chain in Brazil announced he would be open to a buyout. So expect more of these headlines in the months to come.

10/25/2013 - 1:29pm

Many pet owners are confused about pet nutrition and industry standards, according to a new survey.

10/24/2013 - 1:22pm

The growing use of electronic prescribing is driving the growth of cloud computing in health care, according to a new report.